Vigilant Capital Management’s Biogen BIIB Stock Holding History

Vigilant Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100	Closed	-$24K	–	570
2021 Q4	$24K	Buy	+100	New	+$25.7K	﹤0.01%	384
2020 Q4	–	Sell	-300	Closed	-$85K	–	336
2020 Q3	$85K	Buy	+300	New	+$83.7K	0.01%	191
2019 Q3	–	Sell	-161	Closed	-$38K	–	375
2019 Q2	$38K	Sell	161 -39,225	-100%	-$9.06M	0.01%	275
2019 Q1	$9.31M	Buy	39,386 +3,450	+10%	+$1.09M	1.3%	41
2018 Q4	$10.8M	Buy	35,936 +35,714	+16,087%	+$11.4M	1.72%	32
2018 Q3	$78K	Hold	222	–	–	0.01%	225
2018 Q2	$64K	Hold	222	–	–	0.01%	231
2018 Q1	$61K	Buy	222 +171	+335%	+$53.1K	0.01%	213
2017 Q4	$16K	Buy	+51	New	+$16.4K	﹤0.01%	309
2016 Q4	–	Sell	-77	Closed	-$24K	–	271
2016 Q3	$24K	Hold	77	–	–	﹤0.01%	217
2016 Q2	$19K	Buy	+77	New	+$20.3K	﹤0.01%	229

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Vigilant Capital Management's BIIB Position: Q1 2022 in Review

Vigilant Capital Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 100 shares — an estimated $24K sold.

Vigilant Capital Management first reported a position in BIIB in Q2 2016 and held it in 11 quarters. The position peaked at $10.8M in Q4 2018. 952 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

Vigilant Capital Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
Vigilant Capital Management sold 100 Biogen shares in Q1 2022, an estimated $24K.
Vigilant Capital Management first reported a position in Biogen in Q2 2016 and held it in 11 quarters.
Vigilant Capital Management's Biogen position peaked at $10.8M in Q4 2018.
952 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Vigilant Capital Management's 13F filing for Q1 2022, filed 7 Apr 2022.